·
3 MIN READ

For patients struggling with opioids, ED visit can mark new start

Emergency departments emerge as places where opioid-use disorder treatment can be initiated and longer-term care coordinated.

Overdose Epidemic
Two physicians fill out paperwork at a table.
·
5 MIN READ

Amid an epidemic, these physicians are taking action

Doctors encourage non-opioid approaches to pain and safe disposal of unwanted meds, and change the approach to post-surgical prescribing.

Overdose Epidemic
·
2 MIN READ

Nov. 16, 2017: State Advocacy Update

Maine votes to expand Medicaid, Indiana educational webinars on opioids and more in the latest round of state and local advocacy news.

Advocacy Update
Crowd at large AMA meeting listening to a speaker
·
5 MIN READ

AMA: Eliminate burdens for controlled substances’ e-prescribing

Delegates also push for effective opioid-use disorder in jails and prisons and emergency naloxone in public settings.

Interim Meeting
Commentors standing in line at microphone to make a remark.
·
2 MIN READ

Physicians aim to shine light on why drugs cost so much

The AMA will seek to ban unjustified prescription-drug “price gouging” and let pharmacists tell patients when their co-pay exceeds a drug’s cash price.

Public Health
·
3 MIN READ

AMA continues efforts to prevent tobacco use

AMA adopted new policy furthering its longtime support for anti-tobacco efforts aimed at improving public health.

Press Releases
·
4 MIN READ

Former acting U.S. surgeon general earns AMA’s top honor

From ground zero of the Ebola crisis to New York’s ground zero, Boris Lushniak, MD, MPH, served with distinction.

Awards
·
2 MIN READ

AMA expands advocacy efforts supporting drug price transparency

Physicians at the AMA's Interim Meeting adopted new policy to expand the scope of its federal, state advocacy efforts to increase transparency of drug pricing.

Press Releases
Social worker speaking with an opioid patient.
·
4 MIN READ

Time to adopt view of opioid-use disorder as chronic disease

Stigmatization and payers’ use of prior authorization can make it harder to deliver evidence-based treatment to the patients who need it.

Overdose Epidemic